Cerevast Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
2ndary - Private
Cerevast General Information
Description
Developer of medical products and devices designed to be used for the treatment of neurologic disorders. The company's devices use transdermal electrical neurostimulation (TENS) which involves the use of low voltage electric current to modulate nerves for therapeutic purposes, enabling patients to get effective treatment from neurologic disorders and achieve stroke recovery, stress reduction, and sleep.
Contact Information
Website
www.cerevast.comCorporate Office
- 12100 Northeast 195th Street
- Suite 150
- Bothell, WA 98011
- United States
Corporate Office
- 12100 Northeast 195th Street
- Suite 150
- Bothell, WA 98011
- United States
Cerevast Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 01-Jul-2021 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 01-Sep-2015 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 03-Mar-2015 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 22-Apr-2013 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 12-Nov-2011 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 06-Jan-2010 | $2.19M | $3.09M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 18-Sep-2009 | $900K | $900K | Completed | Startup |
Cerevast Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 1,799,700 | $0.000100 | $0.5 | $0.5 | 1x | $0.5 | 16.26% |
Cerevast Patents
Cerevast Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220032089-A1 | Ultrasound visualization, and associated systems and methods | Inactive | 31-Jul-2020 | ||
| WO-2017106411-A1 | Electrodes having surface exclusions | Inactive | 15-Dec-2015 | ||
| WO-2016196635-A2 | Apparatuses and methods for neuromodulation | Inactive | 01-Jun-2015 | ||
| WO-2016196635-A3 | Apparatuses and methods for neuromodulation | Inactive | 01-Jun-2015 | ||
| EP-3302682-A1 | Methods and apparatuses for transdermal electrical stimulation | Inactive | 29-May-2015 | A61N1/0492 |
Cerevast Signals
Cerevast FAQs
-
When was Cerevast founded?
Cerevast was founded in 2009.
-
Where is Cerevast headquartered?
Cerevast is headquartered in Bothell, WA.
-
What is the size of Cerevast?
Cerevast has 5 total employees.
-
What industry is Cerevast in?
Cerevast’s primary industry is Diagnostic Equipment.
-
Is Cerevast a private or public company?
Cerevast is a Private company.
-
What is Cerevast’s current revenue?
The current revenue for Cerevast is .
-
How much funding has Cerevast raised over time?
Cerevast has raised $32.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process